Entrar/Registro  
HOME SPANISH
 
MediSan
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >MediSan >Year 2013, Issue 12


Marten MD, Ramírez ÁMC, Rodríguez RH, Fernández DJ, Cabezas NEP
Impact of triple therapy on patients with peptic ulcer
MediSan 2013; 17 (12)

Language: Español
References: 18
Page: 9126-9132
PDF: 270.86 Kb.

[Full text - PDF]

ABSTRACT

A therapeutic intervention study was conducted in 57 patients who were diagnosed with peptic ulcer at the Endoscopy Department of "Dr. Juan Bruno Zayas Alfonso" Teaching General Hospital of Santiago de Cuba, from September 2009 to the same month of 2010, in order to assess the impact of the triple therapy on this condition. In the series a higher incidence of the peptic ulcer was observed in the group aged 36-45 years, as well as a prevalence of the male sex, with a time of disease progression that exceeded 12 months. Likewise, patients presented with epigastralgia as the most frequent symptom, and erythematous antral gastritis and duodenal ulcer as the most common conditions, with high Helicobacter pylori positivity and a favorable reaction after applying the treatment to eliminate it.


Key words: peptic ulcer, Helicobacter pylori, triple therapy, Endoscopy Department, secondary health care.


REFERENCIAS

  1. Bernardette Lagunes Y, Calva Rodríguez R, Ramírez Téllez E. Prevalencia de Helicobacter pylori en niños sanos de edad escolar. Rev Mex Patol Clin. 2001; 48(1): 23-6.

  2. Gutiérrez Rodríguez DR, Rodríguez Pardillo C, Centillo Díaz N. Helicobacter pylori. Situación gastroenterológica frecuente [citado 15 May 2013]. Disponible en: http://www.portalesmedicos.com/publicaciones/articles/371/1/

  3. Gamboa Figueredo JL. Infección por Helicobacter pylori y enfermedad ulcerosa péptica. Univ Diag. 2003; 3(1): 20-4.

  4. Boixeda de Miguel D, Martín de Argila C. Tratamiento de la infección por Helicobacter pylori. Información Terapéutica del Sistema Nacional de Salud. 2000; 24(6): 141-6.

  5. Pérez Rodríguez A, Mármol Soñora A, González-Carbajal Pascual M, Pérez de Prado Valdivia JC, Herrera Vilches M, Molina Alfonso S, et al. Alteraciones del tracto digestivo superior e infección por el Helicobacter pylori en 23 pacientes receptores del trasplante renal. Reu Cubana Med. 2004 [citado 15 May 2013]; 43(5-6). Disponible en: http://scielo.sld.cu/scielo.php?pid=S0034-75232004 000500001&script=sci_arttext

  6. Peek RM. The biological impact of Helicobacter pylori colonization. Semin Gastrointest Dis. 2001; 12(3): 151-66.

  7. Izquierdo de la Rosa H, Vega Méndez JC, García Barreto RM. Infección por Helicobacter pylori en adultos sintomáticos. Arch Med Camagüey. 2005 [citado 15 May 2013]; 9(2). Disponible en: http://www.amc.sld.cu/amc/2005/v9n2/957.htm

  8. Huerta Igo FM. Sistemas de actualización médica en esófago, estómago y duodeno: Libro 2. Helicobacter pylori: cuándo y a quién tratar. México, D.F.: Intersistemas; 2007. p. 42-51.

  9. Orozco Gámiz A. Estudio abierto prospectivo base de rabeprazol, levofloxacina y amoxicilina para erradicación de Helicobacter pylori en dos semanas. Rev Gastroenterol Mex. 2006; 71(Supl. 2): 91-6.

  10. Moreno Terrones L. 2007 DDW-T-Tratamiento de Helicobacter Pylori. Rev Gastroenterol Mex. 2007; 72(Supl 1): 42-4.

  11. Takáts A, Egri G, Novák J, Csiki Z, Demeter P, Kupcsulik P. Significant decrease of the Helicobacter pylori infection in Budapest. Z Gastroenterol. 2006; 44: 140.

  12. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004; 113(3): 321-33.

  13. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995; 9(Supp 2): 33-9.

  14. Sack DA, Lastovica AJ, Pazzaglia G. Microtiter assay for detecting Campylobacter spp. and Helicobacter pylori with surface gangliosides which bind cholera toxin. J Clin Microbiol. 1998; 38(7): 2043-5.

  15. Akmatsu T, Tabata K, Hironya M, Kawakami H, Uyeda M. Transmission of Helicobacter pylori infection via flexible fiberoptic endoscopy. Am J Infect Control. 1996; 24(5): 396-401.

  16. Gisbert JP. “Rescue” regimens after Helicobacter pylori treatment failure. World J Gastroenterol. 2008; 14(35): 5385-5402.

  17. Vargas JE, Toledo JO. Infección por Helicobacter pylori. Rev Inst Méd Sucre. 2003; 68(122): 31-3.

  18. González Carvajal M, Concepción L. Helicobacter pylori y dispepsia, un problema de salud comentario. MED Gene Integ. 2002; 3: 207-12.






>Journals >MediSan >Year 2013, Issue 12
 

· Journal Index 
· Links 






       
Copyright 2019